Securities code: Shanghai Rightongene Biotechnology Co.Ltd(688217) securities abbreviation: Shanghai Rightongene Biotechnology Co.Ltd(688217) Announcement No.: 2022008
Shanghai Rightongene Biotechnology Co.Ltd(688217)
Announcement on the appointment of securities affairs representatives
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shanghai Rightongene Biotechnology Co.Ltd(688217) (hereinafter referred to as “the company”) was called on March 10, 2022
At the second meeting of the second session of the board of directors, the proposal on the appointment of securities affairs representative was deliberated and adopted. The board of directors agreed to appoint Ms. fan Ming as the company’s securities affairs representative (see the attachment for her resume) to assist the Secretary of the board of directors in carrying out relevant work. Her term of office is from the date of approval by the board of directors to the date of expiration of the second session of the board of directors.
After being appointed, Ms. fan Ming still needs to obtain the qualification certificate of secretary of the board of directors of the science and Innovation Board of Shanghai Stock Exchange, and promises to participate in the qualification training of secretary of the board of directors of the science and Innovation Board of Shanghai Stock Exchange in the near future.
As of the disclosure date of this announcement, Ms. fan Ming does not hold the company’s shares, has no relationship with the company’s controlling shareholder, actual controller, shareholders holding more than 5% shares, other directors, supervisors and senior managers, and has not been punished by the CSRC and other relevant departments or punished and publicly condemned by the stock exchange, It is not suspected of committing a crime and being placed on file for investigation by the judicial organ or being placed on file for inspection by the CSRC for suspected violations of laws and regulations, nor is it a dishonest person to be executed, and there is no situation that it is not allowed to act as the securities affairs representative of the company as stipulated in the company law of the people’s Republic of China and the articles of association.
The contact information of securities affairs representative is as follows:
Tel: 02133282601
Fax: 02137199015
Email: [email protected].
Office address: Building 3, No. 6055, Jinhai Road, Fengxian District, Shanghai
It is hereby announced.
Shanghai Rightongene Biotechnology Co.Ltd(688217) board of directors
March 12, 2022
Attachment: resume of Ms. fan Ming
Fan Ming, female, born in 1995, Chinese nationality, without permanent residency abroad. Bachelor degree, worked in Shanghai Rightongene Biotechnology Co.Ltd(688217) finance department since October 2020, and worked in securities affairs department in December 2021.
